Antinuclear antibodies

Revision as of 16:13, 10 June 2009 by Brian Blank (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Antinuclear antibodies

Articles

Most recent articles on Antinuclear antibodies

Most cited articles on Antinuclear antibodies

Review articles on Antinuclear antibodies

Articles on Antinuclear antibodies in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Antinuclear antibodies

Images of Antinuclear antibodies

Photos of Antinuclear antibodies

Podcasts & MP3s on Antinuclear antibodies

Videos on Antinuclear antibodies

Evidence Based Medicine

Cochrane Collaboration on Antinuclear antibodies

Bandolier on Antinuclear antibodies

TRIP on Antinuclear antibodies

Clinical Trials

Ongoing Trials on Antinuclear antibodies at Clinical Trials.gov

Trial results on Antinuclear antibodies

Clinical Trials on Antinuclear antibodies at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Antinuclear antibodies

NICE Guidance on Antinuclear antibodies

NHS PRODIGY Guidance

FDA on Antinuclear antibodies

CDC on Antinuclear antibodies

Books

Books on Antinuclear antibodies

News

Antinuclear antibodies in the news

Be alerted to news on Antinuclear antibodies

News trends on Antinuclear antibodies

Commentary

Blogs on Antinuclear antibodies

Definitions

Definitions of Antinuclear antibodies

Patient Resources / Community

Patient resources on Antinuclear antibodies

Discussion groups on Antinuclear antibodies

Patient Handouts on Antinuclear antibodies

Directions to Hospitals Treating Antinuclear antibodies

Risk calculators and risk factors for Antinuclear antibodies

Healthcare Provider Resources

Symptoms of Antinuclear antibodies

Causes & Risk Factors for Antinuclear antibodies

Diagnostic studies for Antinuclear antibodies

Treatment of Antinuclear antibodies

Continuing Medical Education (CME)

CME Programs on Antinuclear antibodies

International

Antinuclear antibodies en Espanol

Antinuclear antibodies en Francais

Business

Antinuclear antibodies in the Marketplace

Patents on Antinuclear antibodies

Experimental / Informatics

List of terms related to Antinuclear antibodies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Anti-nuclear antibodies are antibodies directed against the cell nucleus. They are raised in several conditions, usually in an auto-immune condition where the immune system makes antibodies to fight its own body. Normally a test (see External Links) is administered in people with many arthritic type symptoms or skin rashes to exclude systemic lupus erythematosus(SLE). The rashes could be over both cheeks and shaped like a butterfly, or a wolf. They are known to affect almost any part of the body including kidneys and brain.

Interpreting Test Results

  • A high ANA titer may indicate systemic lupus erythematosus (SLE). SLE can be present with titers from 1 to 40 and higher. Almost all people with SLE have a high ANA titer. However, most people with a high ANA titer do not have SLE. Only about one-third of people who are referred to a rheumatologist for high ANA titers are diagnosed with SLE. Other conditions may cause a high ANA titer. About 30% to 40% of people with rheumatoid arthritis have a high ANA titer. [1]
  • Many conditions may result in a high ANA titer. These conditions include autoimmune diseases, such as scleroderma, Sjögren's syndrome, juvenile rheumatoid arthritis, and myositis. Other conditions with a high ANA titer include Raynaud's syndrome, viral infections, and liver disease. Although an ANA titer may help support a diagnosis for these conditions, it is not used by itself to confirm a diagnosis. A thorough medical history, physical examination, and other tests are needed to confirm a suspected autoimmune disease.
  • Some apparently healthy individuals have high levels of antinuclear antibodies. For instance, some people with a family history of autoimmune disease may have a high ANA titer. The higher the titer, however, the more likely it is that the person has an autoimmune disease.
  • Positive ANA is also commonly seen in Sjogren's Syndrome, the second most common auto-immune disease (more common than Lupus)
DISEASE ANA FREQUENCY (%)
Systemic Lupus Erythematosus (SLE) 90-100
Discoid Lupus Erythematosus 21-50
Drug-Induced Lupus 95
Mixed Connective Tissue Disease (MTCD) 100
Scleroderma 31-90
CREST syndrome 95
Rheumatoid Arthritis 10-60
Felty's Syndrome 60-10
Dermatomyositis 40
Autoimmune Chronic Hepatitis 45-100
Myasthenia Gravis 35-50
Immune Thrombocytopenia 50-70
Autoimmune Thyroiditis 40-50
Leukemias 70
Infectious Mononucleosis 30-70

Differential Diagnosis

References

  1. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:26 ISBN 1591032016

External links

Template:SIB


Template:WikiDoc Sources